Status:
NOT_YET_RECRUITING
Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
Lead Sponsor:
Sohag University
Conditions:
Chronic Lymphocytic Leukemia (CLL)- Non-Hodgins's Lymphoma (NHL)
Eligibility:
All Genders
Brief Summary
* Detection of Notch1 mutation in BM or peripheral blood of of patients with NHL * Detection of Notch1 mutation in BM or peripheral blood of of patients with chronic lymphocytic leukemia . * Compariso...
Detailed Description
Chronic Lymphocytic Leukemia (CLL), is the most common leukemia in the western world. with a higher incidence in males (1.7:1),Current treatment strategies vary depending on disease burden, from activ...
Eligibility Criteria
Inclusion
- IncluInclusion criteria: approval to sign an informed written consent, patient with NHL and CLL .
- Exclusion Criteria:
- Refusal to sign an informed written consent, patient on chemotherapy sion Criteria:
Exclusion
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07157579
Start Date
September 1 2025
End Date
September 1 2027
Last Update
September 5 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.